Behind Traditional Semi-quantitative Scores of Myocardial Perfusion Imaging: An Eye on Niche Parameters

Login or register to view PDF.
Abstract

The evaluation of stress-induced myocardial perfusion defects by non-invasive myocardial perfusion imaging (MPI) modalities has a leading role in the identification of coronary artery disease, and has excellent diagnostic and prognostic value. Non-invasive MPI can be performed using conventional and novel gamma cameras or by PET/CT. New software has allowed novel parameters that may have a role in the identification of early marks of cardiac impairment to be evaluated. We aim to give an overview of niche parameters obtainable by single photon emission CT (SPECT) and PET/CT MPI that may help practitioners to detect initial signs of cardiac damage and identify new therapy targets. In particular, we summarise the role of left ventricular geometry indices for remodelling, phase analysis parameters to evaluate mechanical dyssynchrony, the concept of relative flow reserve in the evaluation of flow-limiting epicardial stenosis, vascular age and epicardial adipose tissue as early markers of atherosclerotic burden, and emerging parameters for the evaluation of myocardial innervation, such as the total defect score.

Disclosure
The authors have no conflicts of interest to declare.
Correspondence
Carmela Nappi, Department of Advanced Biomedical Sciences, University Federico II, Via Pansini 5, 80131 Naples, Italy. E: c.nappi@unina.it
Received date
07 January 2019
Accepted date
26 February 2019
Citation
European Cardiology Review 2019;14(1):13–7
DOI
https://doi.org/10.15420/ecr.2019.5.1
Open access
This work is open access under the CC-BY-NC 4.0 License which allows users to copy, redistribute and make derivative works for non-commercial purposes, provided the original work is cited correctly.

Evaluating stress-induced myocardial perfusion defects by non-invasive myocardial perfusion imaging (MPI) modalities has taken a leading role in the identification of flow-limiting epicardial coronary artery disease (CAD); it has excellent diagnostic and prognostic value.

Non-invasive MPI can be performed using conventional and novel gamma cameras or PET/CT.1 A range of imaging techniques has become available and more sophisticated reconstruction algorithms have improved the accuracy of each method, with the crucial benefit of dose reduction.2–4 In addition, the possibility of obtaining a variety of perfusion and functional parameters by using semi-quantitative scores has given a good insight into cardiac function.

The latest single photon emission CT (SPECT) MPI guidelines recommend reporting the extent, severity and reversibility of perfusion defect, ventricular dilatation and transient ischaemic dilation (TID).5 In particular, the TID ratio adds value to clinical and perfusion data to identify the presence of severe CAD in patients with suspected or known CAD, especially in those with diabetes.6 When ECG-gated CT is performed, it is necessary to evaluate regional wall motion and thickening and to report the ejection fraction after stress and/or at rest.

Non-invasive quantification of myocardial blood flow (MBF) and coronary flow reserve (CFR) by PET/CT increase the scope of conventional SPECT MPI from the evaluation of advanced CAD to the assessment of early stages of atherosclerosis or microvascular dysfunction and the identification of balanced ischaemia with reduction of MBF in all three major coronary arteries.7 Integrating functional data with information derived from coronary CT provides incremental information about coronary artery morphology and coronary calcium burden.8–10 New software has allowed novel parameters that may have a role in the identification of early marks of cardiac impairment to be evaluated.

We aim to give an overview on niche parameters obtainable by SPECT and PET/CT MPI that may help clinicians to detect the initial signs of cardiac damage and new therapy targets.

MPI Niche Parameters

Left Ventricular Geometry

Left ventricle (LV) geometry changes in response to exposure to cardiovascular risk factors. This is significant, given that LV remodelling is associated with poorer outcomes.11 The LV can change its structure considerably in relatively short periods of time, with the potential for pathological remodelling to be reversed to some degree.12 Previous studies have examined the relationship between cardiac volumes, ejection fraction and remodelling.13

Several non-invasive imaging techniques can be used to evaluate different structural modifications in myocardial tissue. Ultrasound and MRI studies take a two-dimensional approach to evaluate LV geometry by manual measurements obtained from perpendicular views.14–15 However, these techniques are subject to variability and depend on the experience of the operator.

Examples Of Abnormal And Normal Geometry

Open in new tab

Cardiac CT Images Of Two Patients With Different Epicardial Adipose Tissue Values

Open in new tab

Quantitative gated SPECT allows 2D and 3D LV geometry to be evaluated, providing remodelling parameters, such as eccentricity and the end-diastolic and end-systolic LV shape index (LVSI), which are automatically generated by QGS software (QGIS Development Team).16 Specifically, eccentricity is a measure of the elongation of the LV, and varies from 0 (sphere) to 1 (line); it is calculated from the major and the minor axes of the ellipsoid that best fits the mid-myocardial surface, while LVSI is calculated as the ratio of the maximum 3D short- and long-axis LV dimension, at end-diastole and at end-systole by applying the algorithm proposed by Abidov et al.17

The closer the dimensions of the axes are, the more the ellipsoid takes the shape of a sphere (Figure 1). These parameters are highly repeatable and have been shown to have clinical utility in identifying not only patients with an exacerbation of cardiac heart failure but also early LV remodelling in patients with diabetes, demonstrating a prognostic value, even in the presence of normal myocardial perfusion.18–20 However, no studies to examine the role of these indices in the evaluation of reverse remodelling have yet been conducted.

Phase Analysis

Speckle-tracking echocardiography, cardiac MRI and nuclear imaging have allowed LV mechanical dyssynchrony to be evaluated, providing quantitative measurements of mechanical delay.21 Phase analysis by gated SPECT evaluates temporal sequence of contraction, using continuous Fourier harmonic functions, to analyse LV synchronic contraction.

Phase analysis parameters of gated SPECT at rest can be calculated using dedicated software and provides five quantitative indices (P, SD, B, S, and K) from the phase histogram to describe the phase histogram’s characteristics (time of onset, dispersion, symmetry and envelope) of the LV regional onset of mechanical contraction to quantify dyssynchrony. P is the most frequent phase (the phase corresponding to the peak of the phase histogram). SD is the standard deviation of the phase distribution. B includes 95% of the elements in the phase distribution. S indicates the symmetry of the histogram (positive S indicates the histogram skewed to the right with a longer tail to the right of the peak phase). K (kurtosis) indicates the degree to which the histogram has peaked; a histogram with a higher peak within a narrower band has higher kurtosis.22 Recently, cut-off values for SD, bandwidth (BW), skewness (S) and kurtosis (K) obtained from gated SPECT that show a good discriminatory capacity between healthy patients and those with varying degrees of cardiac mechanical dyssynchrony were suggested.23 Evaluation of mechanical dyssynchrony predicts response to resynchronisation therapy with long-term prognostic value.24–25

A method that automatically integrates the myocardial viability polar map and the polar map of LV regional contraction synchronicity from gated SPECT could be used to detect the latest contracting viable left ventricular segments and help guide resynchronization therapy.26 In a small population of patients with acute MI and multivessel disease who had undergone successful revascularisation of the culprit arteries, stress phase SD and stress histogram BW were independent predictors of events, which suggests an intriguing application of phase analysis.27

In the light of high prognostic value of such parameters, standardised cut-off values could potentially help cardiologists to interpret imaging to provide more tailored therapeutic strategies.

Relative Flow Reserve

Alongside widely validated quantitative parameters derived from PET, such as MBF and CFR, the concept of relative flow reserve (RFR) has been proposed; this is defined as the ratio of hyperaemic MBF in a stenotic area to hyperaemic MBF in a normally perfused area.28 The increasing interest on this new variable originates from the need to find an accurate, noninvasive indicator of flow-limiting coronary stenosis.

The literature has reported discrepancies regarding the relationship between conventional PET-derived measurements and invasive index significant epicardial stenosis. For example, fractional flow reserve (FFR) has a well-established inverse relationship with outcomes; lesions with lower FFR values receive greater absolute benefits from revascularisation.29,30

Even if hyperaemic MBF had a better correlation with FFR than CFR, the parameters look at different pathophysiological processes: hyperaemic MBF not only measures the entire single coronary vascular bed affected by an epicardial stenosis but also indicates microvascular resistance. Therefore, a reduced hyperaemic MBF may be an epiphenomenon of two different kind of coronary vascular damage and it cannot separate the effects of a specific lesion from those of microvascular dysfunction. RFR shows a linear correspondence with FFR and it has been reported that RFR of 0.70–0.80 predicts FFR ≤0.8 with good diagnostic performance.31 A recent study used PET-derived CFR and RFR as references to compare the diagnostic performance between FFR and resting indices in predicting ischaemia.32 However, prognostic data are needed to validate this new variable.

Vascular Age

From hybrid techniques for MPI, such as PET/CT, some parameters have emerged as additional, earlier marks of cardiovascular impairment. Vascular age, for example, is a novel variable based on the logarithmic transformation of the coronary artery calcium (CAC) score measured in Agatston units into a theoretical age in years that better identifies degeneration in the vascular system than chronological age due to calcium deposit.33 Calculating the CAC score already has a primary role in atherosclerosis evaluation. Clinical practice guidelines in the US and Europe consider CAC scoring could improve cardiovascular risk assessment in asymptomatic people and guide preventive therapies.34,35 Of note, it has been widely demonstrated that patients with suspected CAD without evidence of coronary calcium do not need further cardiac imaging investigations.36–39

This emerging concept of assigning a vascular age to patients undergoing coronary CT is based on evidence that plaques in elderly patients are more calcified than those in younger patients. The findings of large-scale studies, including the Multi-Ethnic Study of Atherosclerosis (MESA) and the St Francis Heart Study, demonstrate that vascular age is better for risk assessment because it is a much stronger predictor of cardiovascular events than chronological age.40,41

Recently, we demonstrated that coronary vascular age, assessed using CAC score, is associated with stress-induced myocardial ischaemia in patients with suspected CAD and this marker appears to be more accurate than chronological age in predicting ischaemia.42 Therefore, vascular age has a better clinical utility when making decisions on therapies and healthier lifestyles.

Epicardial Adipose Tissue

Epicardial adipose tissue (EAT) is the heart’s fat storehouse. It is located between the myocardium and pericardium, sharing the same perfusion of the heart with no barrier.43 It produces different bioactive substances that can affect cardiac function.44

It is increasingly thought that the traditional anthropometric indices of pathological obesity such as BMI and body surface area may not identify obese patients who have an increased risk of cardiovascular events.45,46 EAT can be measured using different modalities and indicators. While echocardiography allows the evaluation of EAT thickness with good reproducibility, it does not provide an estimation of the total epicardial fat amount; however, cardiac CT (Figure 2) and MRI give detailed volumetric quantification of fat load with high reproducibility.47

Patient With Heart Failure And Reduced Early And Late Heart:Mediastinum Ratios

Open in new tab

It has been recently observed that increased EAT volume is associated with coronary calcium burden, inflammatory markers and poorer outcomes; it also associated with cardiac sympathetic denervation, which can lead to catecholamine production in a cardiac response to sympathetic stimuli.48,49

Therefore, EAT evaluation could play a part in the atherosclerosis development and may be considered a marker and a therapeutic target at the same time.

Behind and Beyond Myocardial Perfusion Imaging: Myocardial Innervation

Both myocardial perfusion and innervation can be studied by conventional and novel gamma cameras. Cardiac neuronal function is compromised in a number of cardiac diseases. Therefore, the evaluation of functional and electrophysiological properties of the autonomic nervous system at cardiac level has become a focus of interest in the field of cardiovascular imaging.50 A number of radiopharmaceuticals are used to investigate autonomic neuronal functions.51 It has been widely demonstrated that the status of catecholamine storage at the level of the myocardial sympathetic presynaptic fibres can be assessed with 123I-labelled meta-iodobenzylguanidine (123I-MIBG).52–54 In addition to the traditional evaluation of heart:mediastinum (H:M) ratios obtained by early and late planar acquisitions, the innervation defect size can be measured by performing supplementary tomographic imaging.

From SPECT images, tracer uptake can be assessed semi-quantitatively using the 17-segment model and a 5-point scale: 0 = normal uptake; 1 = mildly reduced uptake; 2 = moderately reduced uptake; 3 = severely reduced uptake; and 4 = no uptake. The total defect score (TDS) can be calculated on the polar maps by the sum of the 17 segmental tracer uptake scores. Therefore, the innervation defect size can be expressed as percentage of the total enervated myocardium (% LV) using the formula: TDS/68 × 100, where 68 is the maximum TDS in the 17-segment model. Defect severity, as defined by TSD on 123I-MIBG SPECT using a conventional Anger camera, is significantly associated with inducible ventricular tachyarrhythmia in patients with left ventricular dysfunction and previous MI.56

Extensive Left Ventricular Adrenergic Denervation And Preserved Myocardial Perfusion

Open in new tab

Imbriaco et al. recently showed that sympathetic neuronal damage evaluated by TDS obtained from 123I-MIBG imaging might detect cardiac involvement at an early stage in patients with Anderson-Fabry disease, leading to straight therapeutic strategies in patients prone to LV fibrosis development.57

The addition of SPECT method on 123I-MIBG imaging overcomes the limitations in the interpretation of planar acquisition, such as the superposition of noncardiac structures and lack of segmental analysis, and improves the clinical utility of this technique for diagnosis and prognosis. However, visual scoring of 123I-MIBG SPECT images is challenging and they need to be compared to normal data files. Moreover, SPECT requires longer acquisition time so can be performed only in fully collaborative patients.

Future directions

The recent introduction of solid-state cardiac cameras with cadmium-zinc-telluride (CZT) detectors, which have higher photon sensitivity and spatial resolution than standard cameras, may allow parameters obtained by 123I-MIBG SPECT imaging to be used to gain a more accurate evaluation of cardiac adrenergic activity (Figure 3). Moreover, the possibility of obtaining both planar equivalent images and SPECT data during the same acquisition, thanks to the advanced geometry of these cameras, makes the examination shorter and more comfortable.

Furthermore, the narrower energy windows and better photon energy discrimination of CZT technology allow simultaneous 99mTc-sestamibi/123I-MIBG dual isotope imaging with a significant reduction in down-scatter of the two isotopes’ photopeaks.58–61 From this perspective, the possibility of viewing myocardial perfusion and innervation in one imaging session (Figure 4), combined with the opportunity to obtain more accurate parameters for innervation evaluation such as TSD, offers significant potential.

The extensive pool of available data has prepared the ground for the challenge of the future that is the use of machine learning and artificial intelligence for clinical applications. Machine learning is the area of computer science that exploit available information to produce reliable and repeatable choices to guide clinical decision-making. This approach seems very promising in the era of personalised medicine.62–64

The integration of information derived from traditional and novel parameters with data obtained from demographics may have a role in driving diagnostic work-up in individual patients, making medical care more personalised. However, this requires a great deal of measurement and evaluation, from image acquisition, through imaging parameters generation and developing decision-making algorithms before a critical clinical choice therapy based on human critical thinking rather than choice generated by machine algorithm can be made.

References
  1. Gibbons RJ. Myocardial perfusion imaging. Heart 2000;83:355–60. https://doi.org/10.1136/heart.83.3.355; PMID: 10677421.
  2. Schaefferkoetter J, Ouyang J, Rakvongthai Y, et al. Effect of time-of-flight and point spread function modeling on detectability of myocardial defects in PET. Med Phys 2014;41:062502. https://doi.org/10.1118/1.4875725; PMID: 24877836.
  3. Nappi C, Acampa W, Nicolai E, et al. Long-term prognostic value of low-dose normal stress-only myocardial perfusion imaging by wide beam reconstruction: a competing risk analysis. J Nucl Cardiol 2018. https://doi.org/10.1007/s12350-018-1373-x; PMID: 30027504; epub ahead of press.
  4. Brambilla M, Lecchi M, Matheoud R, et al. Comparative analysis of iterative reconstruction algorithms with resolution recovery and new solid state cameras dedicated to myocardial perfusion imaging. Phys Med 2017;41:109–16. https://doi.org/10.1016/j.ejmp.2017.03.008; PMID: 28343906.
  5. Dorbala S, Ananthasubramaniam K, Armstrong IS, et al. Single photon emission computed tomography (SPECT) myocardial perfusion imaging guidelines: instrumentation, acquisition, processing, and interpretation. J Nucl Cardiol 2018;25:1784–846. https://doi.org/10.1007/s12350-018-1283-y; PMID: 29802599.
  6. Petretta M, Acampa W, Daniele S, et al. Transient ischemic dilation in SPECT myocardial perfusion imaging for prediction of severe coronary artery disease in diabetic patients. J Nucl Cardiol 2013;20:45–52. https://doi.org/10.1007/s12350-012-9642-6; PMID: 23090352.
  7. Dilsizian V, Bacharach SL, Beanlands RS, et al. ASNC imaging guidelines/SNMMI procedure standard for positron emission tomography (PET) nuclear cardiology procedures. J Nucl Cardiol 2016;23:187–1226. https://doi.org/10.1007/s12350-016-0522-3; PMID: 27392702
  8. Zampella E, Acampa W, Assante R, et al. Combined evaluation of regional coronary artery calcium and myocardial perfusion by 82Rb PET/CT in the identification of obstructive coronary artery disease. Eur J Nucl Med Mol Imaging 2018;45:521–9. https://doi.org/10.1007/s00259-018-3935-1; PMID: 29372272.
  9. Assante R, Acampa W, Zampella E, et al. Prognostic value of atherosclerotic burden and coronary vascular function in patients with suspected coronary artery disease. Eur J Nucl Med Mol Imaging 2017;44:2290–8. https://doi.org/10.1007/s00259-017-3800-7; PMID: 28815291
  10. Assante R, Acampa W, Zampella E, et al. Coronary atherosclerotic burden vs coronary vascular function in diabetic and nondiabetic patients with normal myocardial perfusion: a propensity score analysis. Eur J Nucl Med Mol Imaging 2017;44:1129–35. https://doi.org/10.1007/s00259-017-3671-y; PMID: 28293706.
  11. Lieb W, Gona P, Larson MG, et al. The natural history of left ventricular geometry in the community: clinical correlates and prognostic significance of change in LV geometric pattern. JACC Cardiovasc Imaging 2014;7:870–8. https://doi.org/10.1016/j.jcmg.2014.05.008; PMID: 25129518.
  12. Hill JA, Olson EN. Cardiac plasticity. N Engl J Med 2008;358:1370–80. https://doi.org/10.1056/NEJMra072139; PMID: 18367740.
  13. Udelson JE. Left ventricular shape: the forgotten stepchild of remodeling parameters. JACC Heart Fail 2017;5:179–81. https://doi.org/10.1016/j.jchf.2017.01.005; PMID: 28254123.
  14. Ernande L, Rietzschel ER, Bergerot C, et al. Impaired myocardial radial function in asymptomatic patients with type 2 diabetes mellitus: a speckle-tracking imaging study. J Am Soc Echocardiogr 2010;23:1266–72. https://doi.org/10.1016/j.echo.2010.09.007; PMID: 20932716
  15. Aquaro GD, Camastra G, Monti L, et al. Reference values of cardiac volumes, dimensions, and new functional parameters by MR: a multicenter, multivendor study. J Magn Reson Imaging 2017;45:1055–67. https://doi.org/10.1002/jmri.25450; PMID: 27571232.
  16. Germano G, Kavanagh PB, Slomka PJ, et al. Quantitation in gated perfusion SPECT imaging: the Cedars-Sinai approach. J Nucl Cardiol 2007;14:433–54. https://doi.org/10.1016/j.nuclcard.2007.06.008; PMID: 17679052.
  17. Abidov A, Slomka PJ, Nishina H, et al. Left ventricular shape index assessed by gated stress myocardial perfusion SPECT: initial description of a new variable. J Nucl Cardiol 2006; 13:652–9. https://doi.org/10.1016/j.nuclcard.2006.05.020; PMID: 16945745.
  18. Nappi C, Gaudieri V, Acampa W, et al. Comparison of left ventricular shape by gated SPECT imaging in diabetic and nondiabetic patients with normal myocardial perfusion: a propensity score analysis. J Nucl Cardiol 2018;25:394–403. https://doi.org/10.1007/s12350-017-1009-6; PMID: 28808939.
  19. Pfeffer MA, Braunwald E. Ventricular remodeling after myocardial infarction. Experimental observations and clinical implications. Circulation 1990;81:1161–72. https://doi.org/10.1161/01.CIR.81.4.1161; PMID: 2138525.
  20. Gaudieri V, Nappi C, Acampa W, et al. Added prognostic value of left ventricular shape by gated SPECT imaging in patients with suspected coronary artery disease and normal myocardial perfusion. J Nucl Cardiol 2017. https://doi.org/10.1007/s12350-017-1090-x; PMID: 29071670; epub ahead of press.
  21. Khidir MJ, Delgado V, Ajmone Marsan N, Bax JJ. Mechanical dyssynchrony in patients with heart failure and reduced ejection fraction: how to measure? Curr Opin Cardiol 2016;31:523–30. https://doi.org/10.1097/HCO.0000000000000314; PMID: 27322767.
  22. Romero-Farina G, Aguadé-Bruix S, Candell-Riera J, et al. Cut-off values of myocardial perfusion gated-SPECT phase analysis parameters of normal subjects, and conduction and mechanical cardiac diseases. J Nucl Cardiol 2015;22:1247–58. https://doi.org/10.1007/s12350-015-0143-2; PMID: 26017712.
  23. Aguadé-Bruix S, Romero-Farina G. Mechanical dyssynchrony according to validated cut-off values using gated SPECT myocardial perfusion imaging. J Nucl Cardiol 2018;25:1039. https://doi.org/10.1007/s12350-017-0791-5; PMID: 28150153.
  24. Pazhenkottil AP, Buechel RR, Husmann L, et al. Long-term prognostic value of left ventricular dyssynchrony assessment by phase analysis from myocardial perfusion imaging. Heart 2011; 97:33–7. https://doi.org/10.1136/hrt.2010.201566; PMID: 20962345.
  25. Petretta M, Petretta A, Cuocolo A. Assessment of asynchrony by gated myocardial perfusion imaging improves patient management: Pro. J Nucl Cardiol 2018;25:532–5. https://doi.org/10.1007/s12350-017-1021-x; PMID: 28795346.
  26. Zhou W, Tao N, Hou X, et al. Development and validation of an automatic method to detect the latest contracting viable left ventricular segments to assist guide CRT therapy from gated SPECT myocardial perfusion imaging. J Nucl Cardiol 2018;25:1948–57. https://doi.org/10.1007/s12350-017-0853-8; PMID: 28353213.
  27. Cho SG, Jabin Z, Park KS, et al. Clinical values of left ventricular mechanical dyssynchrony assessment by gated myocardial perfusion SPECT in patients with acute myocardial infarction and multivessel disease. Eur J Nucl Med Mol Imaging 2017;44(2):259–66. https://doi.org/10.1007/s00259-016-3542-y; PMID: 27752746.
  28. Stuijfzand WJ, Uusitalo V, Kero T, et al. Relative flow reserve derived from quantitative perfusion imaging may not outperform stress myocardial blood flow for identification of hemodynamically significant coronary artery disease. Circ Cardiovasc Imaging 2015;8:pii: e002400. https://doi.org/10.1161/CIRCIMAGING.114.002400; PMID: 25596142.
  29. Johnson NP, Kirkeeide RL, Gould KL. Is discordance of coronary flow reserve and fractional flow reserve due to methodology or clinically relevant coronary pathophysiology? JACC Cardiovasc Imaging 2012;5:193–202. https://doi.org/10.1016/j.jcmg.2011.09.020
  30. Johnson NP, Tóth GG, Lai D, et al. Prognostic value of fractional flow reserve: linking physiologic severity to clinical outcomes. J Am Coll Cardiol 2014;64:1641–54. https://doi.org/10.1016/j.jacc.2014.07.973; PMID: 25323250.
  31. Johnson NP, Gould KL. Fractional flow reserve returns to its origins: quantitative cardiac positron emission tomography. Circ Cardiovasc Imaging 2016;9:e005435. https://doi.org/10.1161/CIRCIMAGING.116.005435; PMID: 27609820.
  32. De Bruyne B, Baudhuin T, Melin JA, et al. Coronary flow reserve calculated from pressure measurements in humans. Validation with positron emission tomography. Circulation 1994;89:1013–22. https://doi.org/10.1161/01.CIR.89.3.1013; PMID: 8124786.
  33. Cuocolo A, Klain M, Petretta M. Coronary vascular age comes of age. J Nucl Cardiol 2017;24:1835–6. https://doi.org/10.1007/s12350-017-1078-6; PMID: 28975506.
  34. Goff DC Jr, Lloyd-Jones DM, Bennett G, et al. 2013 ACC/AHA guideline on the assessment of cardiovascular risk: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. J Am Coll Cardiol 2014;63:2935–59. https://doi.org/10.1016/j.jacc.2013.11.005; PMID: 24239921. .
  35. Piepoli MF, Hoes AW, Agewall S, et al. 2016 European guidelines on cardiovascular disease prevention in clinical practice. Eur Heart J 2016;37:2315–81. https://doi.org/10.1093/eurheartj/ehw106; PMID: 27222591.
  36. Nappi C, Nicolai E, Daniele S, et al. Long-term prognostic value of coronary artery calcium scanning, coronary computed tomographic angiography and stress myocardial perfusion imaging in patients with suspected coronary artery disease. J Nucl Cardiol 2018;25:833–41. https://doi.org/10.1007/s12350-016-0657-2; PMID: 27804072.
  37. Naya M, Tamaki N. Stress MPI, coronary CTA, and multimodality for subsequent risk analysis. J Nucl Cardiol 2016;23:198–201. https://doi.org/10.1007/s12350-016-0400-z; PMID: 26797921.
  38. Cantoni V, Green R, Acampa W, et al. Long-term prognostic value of stress myocardial perfusion imaging and coronary computed tomography angiography: a meta-analysis. J Nucl Cardiol 2016; 23:185–97. https://doi.org/10.1007/s12350-015-0349-3; PMID: 26758375.
  39. Chang SM, Nabi F, Xu J, et al. The coronary artery calcium score and stress myocardial perfusion imaging provide independent and complementary prediction of cardiac risk. J Am Coll Cardiol 2009;54:1872–82. https://doi.org/10.1016/j.jacc.2009.05.071; PMID: 19892239.
  40. McClelland RL, Chung H, Detrano R, et al. Distribution of coronary artery calcium by race, gender, and age: results from the Multi-Ethnic Study of Atherosclerosis (MESA). Circulation 2006;113:30–7. https://doi.org/10.1161/CIRCULATIONAHA.105.580696; PMID: 16365194.
  41. McClelland RL, Jorgensen NW, Budoff M, et al. 10-year coronary heart disease risk prediction using coronary artery calcium and traditional risk factors: derivation in the MESA (Multi-Ethnic Study of Atherosclerosis) with validation in the HNR (Heinz Nixdorf Recall) study and the DHS (Dallas Heart Study). J Am Coll Cardiol 2015;66:1643–53. https://doi.org/10.1016/j.jacc.2015.08.035; PMID: 26449133.
  42. Nappi C, Gaudieri V, Acampa W, et al. Coronary vascular age: an alternate means for predicting stress-induced myocardial ischemia in patients with suspected coronary artery disease. J Nucl Cardiol 2018. https://doi.org/10.1007/s12350-018-1191-1; PMID: 29359274; epub ahead of press.
  43. Fitzgibbons TP, Czech MP. Epicardial and perivascular adipose tissues and their influence on cardiovascular disease: basic mechanisms and clinical associations. J Am Heart Assoc 2014;3:e000582. https://doi.org/10.1161/JAHA.113.000582; PMID: 24595191.
  44. Iacobellis G, Corradi D, Sharma AM. Epicardial adipose tissue: anatomic, biomolecular and clinical relationships with the heart. Nat Clin Pract Cardiovasc Med 2005;2:536–43. https://doi.org/10.1038/ncpcardio0319; PMID: 16186852.
  45. Iwasaki K, Urabe N, Kitagawa A, Nagao T. The association of epicardial fat volume with coronary characteristics and clinical outcome. Int J Cardiovasc Imaging 2018;34:301–9. https://doi.org/10.1007/s10554-017-1227-7; PMID: 28808885.
  46. Ng AC, Strudwick M, van der Geest RJ, et al. Impact of epicardial adipose tissue, left ventricular myocardial fat content, and interstitial fibrosis on myocardial contractile function. Circ Cardiovasc Imaging 2018;11:e007372. https://doi.org/10.1161/CIRCIMAGING.117.007372; PMID: 30354491.
  47. Antonopoulos AS, Antoniades C. Cardiac magnetic resonance imaging of epicardial and intramyocardial adiposity as an early sign of myocardial disease. Circ Cardiovasc Imaging 2018;11:e008083. https://doi.org/10.1161/CIRCIMAGING.118.008083; PMID: 30354506.
  48. Goeller M, Achenbach S, Marwan M, et al. Epicardial adipose tissue density and volume are related to subclinical atherosclerosis, inflammation and major adverse cardiac events in asymptomatic subjects. J Cardiovasc Comput Tomogr 2018;12:67–73. https://doi.org/10.1016/j.jcct.2017.11.007; PMID: 29233634.
  49. Parisi V, Rengo G, Perrone-Filardi P, et al. Increased epicardial adipose tissue volume correlates with cardiac sympathetic denervation in patients with heart failure. Circ Res 2016;118:1244–53. https://doi.org/10.1161/CIRCRESAHA.115.307765; PMID: 26926470.
  50. Rengo G, Pagano G, Vitale DF, et al. Impact of aging on cardiac sympathetic innervation measured by 123I-mIBG imaging in patients with systolic heart failure. Eur J Nucl Med Mol Imaging 2016;43:2392–400. https://doi.org/10.1007/s00259-016-3432-3; PMID: 27287990.
  51. Nappi C, Acampa W, Pellegrino T, et al. Beyond ultrasound: advances in multimodality cardiac imaging. Intern Emerg Med 2015;10:9–20. https://doi.org/10.1007/s11739-014-1106-3; PMID: 25037458.
  52. Tamaki N, Kuge Y, Yoshinaga K. Molecular imaging in heart failure patients. Clin Transl Imaging 2013;1:341–51. https://doi.org/10.1007/s40336-013-0034-y; PMID: 24765617.
  53. Perrone-Filardi P, Paolillo S, Dellegrottaglie S, et al. Assessment of cardiac sympathetic activity by MIBG imaging in patients with heart failure: a clinical appraisal. Heart 2011;97:1828–33. https://doi.org/10.1136/heartjnl-2011-300343; PMID: 21917663.
  54. De Lucia C, Gambino G, Petraglia L, et al. Long-term caloric restriction improves cardiac function, remodeling, adrenergic responsiveness, and sympathetic innervation in a model of postischemic heart failure. Circ Heart Fail 2018;11:e004153. https://doi.org/10.1161/CIRCHEARTFAILURE.117.004153; PMID: 29535114.
  55. Flotats A, Carrió I, Agostini D, et al. Proposal for standardization of 123I-metaiodobenzylguanidine (MIBG) cardiac sympathetic imaging by the EANM Cardiovascular Committee and the European Council of Nuclear Cardiology. Eur J Nucl Med Mol Imaging 2010;37:1802–12. https://doi.org/10.1007/s00259-010-1491-4; PMID: 20577740.
  56. Bax JJ, Kraft OR, Buxton AE, et al. 123 I-mIBG scintigraphy to predict inducibility of ventricular arrhythmias on cardiac electrophysiology testing: a prospective multicenter pilot study. Circ Cardiovasc Imaging 2008;1:131–40. https://doi.org/10.1161/CIRCIMAGING.108.782433; PMID: 19808530.
  57. Imbriaco M, Pellegrino T, Piscopo V, et al. Cardiac sympathetic neuronal damage precedes myocardial fibrosis in patients with Anderson-Fabry disease. Eur J Nucl Med Mol Imaging 2017;44:2266–73. https://doi.org/10.1007/s00259–017-3778-1; PMID: 28733764.
  58. Blaire T, Bailliez A, Ben Bouallegue F, et al. First assessment of simultaneous dual isotope (123I/99mTc) cardiac SPECT on two different CZT cameras: a phantom study. J Nucl Cardiol 2018;25:1692–704. https://doi.org/10.1007/s12350-017-0841-z; PMID: 28275896.
  59. Blaire T, Bailliez A, Ben Bouallegue F, et al. Determination of the heart-to-mediastinum ratio of 123I-MIBG uptake using dual-isotope (123I-MIBG/99mTc-tetrofosmin) multipinhole cadmium-zinc-telluride SPECT in patients with heart failure. J Nucl Med 2018;59:251–8. https://doi.org/10.2967/jnumed.117.194373; PMID: 28646015.
  60. Zampella E, Nappi C, Acampa W. Simultaneous dual isotope 201Tl/99mTc myocardial perfusion imaging using CZT cameras: clinical utility or technical challenge? J Nucl Cardiol 2018. https://doi.org/10.1007/s12350-018-01522-w; PMID: 30478659; epub ahead of press.
  61. Juarez-Orozco LE, Knol RJJ, Sanchez-Catasus CA, et al. Machine learning in the integration of simple variables for identifying patients with myocardial ischemia. J Nucl Cardiol 2018. https://doi.org/10.1007/s12350-018-1304-x; PMID: 29790017; epub ahead of press.
  62. Gomez J, Doukky R, Germano G, Slomka P. New trends in quantitative nuclear cardiology methods. Curr Cardiovasc Imaging Rep 2018;11:1. https://doi.org/10.1007/s12410-018-9443-7; PMID: 30294409.
  63. Nappi C, Cuocolo A. The machine learning approach: artificial intelligence is coming to support critical clinical thinking. J Nucl Cardiol 2018. https://doi.org/10.1007/s12350-018-1344-2; PMID: 29923100; epub ahead of press.